EMA — authorised 8 January 2018
- Marketing authorisation holder: AstraZeneca AB
- Status: approved
🇪🇺 Fasenra in European Union
EMA authorised Fasenra on 8 January 2018
Marketing authorisation
Fasenra in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in European Union
Frequently asked questions
Is Fasenra approved in European Union?
Yes. EMA authorised it on 8 January 2018.
Who is the marketing authorisation holder for Fasenra in European Union?
AstraZeneca AB holds the EU marketing authorisation.